https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-needham-virtual-growth-conference-2022-01-03
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2022-second-quarter-financial-results-on-january-6
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2022-first-quarter-financial-results-updates-guidance
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2022-first-quarter-financial-results-on-september-30
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-canaccord-genuity-virtual-growth-conference-2021-07
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2021-fourth-quarter-and-full-year-financial-results-2021
https://www.nasdaq.com/press-release/angiodynamics-announces-details-for-investor-technology-day-on-july-13-2021-2021-07
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2021-fourth-quarter-and-full-year-financial-results
https://www.nasdaq.com/press-release/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-ubs-virtual-global-healthcare-conference-2021-05-17
https://www.nasdaq.com/press-release/angiodynamics-submits-510k-application-to-fda-for-alphavac-mechanical-thrombectomy
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-needham-virtual-healthcare-conference-2021-04-05
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2021-third-quarter-financial-results-and-updates
https://www.nasdaq.com/press-release/angiodynamics-to-participate-in-a-virtual-fireside-chat-at-the-keybanc-life-sciences
https://www.nasdaq.com/press-release/angiodynamics-to-participate-in-a-virtual-fireside-chat-at-the-oppenheimer-healthcare
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2021-third-quarter-financial-results-on-march-30-2021
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-barclays-virtual-global-healthcare-conference-2021-03
https://www.nasdaq.com/press-release/angiodynamics-appoints-richard-c.-rosenzweig-senior-vice-president-general-counsel
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2021-second-quarter-financial-results-2021-01-07
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-j.p.-morgan-virtual-healthcare-conference-2021-01-04
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-needham-virtual-growth-conference-2020-12-29
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2021-second-quarter-financial-results-on-january-7
https://www.nasdaq.com/press-release/angiodynamics-announces-presentation-of-positive-safety-efficacy-results-from-rapid
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2021-first-quarter-financial-results-2020-09-29
https://www.nasdaq.com/press-release/angiodynamics-announces-commercial-launch-of-auryon-atherectomy-system-in-united
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2021-first-quarter-financial-results-on-september-29
https://www.nasdaq.com/press-release/angiodynamics-announces-first-patient-enrolled-in-pathfinder-i-registry-examining
https://www.nasdaq.com/press-release/angiodynamics-to-participate-in-a-virtual-fireside-chat-at-the-canaccord-genuity
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2020-fourth-quarter-and-full-year-financial-results-2020
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2020-fourth-quarter-and-full-year-financial-results-on
https://www.nasdaq.com/press-release/angiodynamics-to-participate-in-a-virtual-fireside-chat-at-the-raymond-james-human
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-ubs-virtual-global-healthcare-conference-2020-05-07
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2020-third-quarter-financial-results-2020-04-07
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2020-third-quarter-financial-results-on-april-7-2020
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-two-investor-conferences-in-march-2020-02-27
https://www.nasdaq.com/press-release/angiodynamics-appoints-stephen-trowbridge-executive-vice-president-and-chief
https://www.nasdaq.com/press-release/angiodynamics-launches-pathfinder-i-registry-to-evaluate-performance-and-clinical
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2020-second-quarter-financial-results-2020-01-07
https://www.nasdaq.com/press-release/angiodynamics-to-present-at-the-j.p.-morgan-healthcare-conference-2020-01-06
https://www.nasdaq.com/press-release/angiodynamics-to-report-fiscal-2020-second-quarter-financial-results-on-january-7
https://www.nasdaq.com/press-release/angiodynamics-announces-departure-of-cfo-and-appointment-of-interim-cfo-2019-10-22
https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2020-first-quarter-financial-results-2019-10-03
https://www.nasdaq.com/press-release/angiodynamics-acquires-eximo-medical-ltd.-and-its-innovative-355nm-laser-atherectomy
https://www.nasdaq.com/press-release/angiodynamics-awarded-premiers-nationally-outsourced-implantable-infusion-port
